# OnCo record vnx-202 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vnx-202/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vnx-202" ;
  schema:name "VNX-202"@en ;
  schema:alternateName "AAV.CD3/HER2"@en ;
  schema:description "VNX-202 is an experimental in vivo gene therapy: AAV vector encoding a bispecific T-cell engager from Vironexis Biotherapeutics, in phase 1 trials for HER2-expressing solid tumours."@en ;
  schema:url <https://onco.cc/drugs/vnx-202/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://vironexis.com>, <https://clinicaltrials.gov/api/v2/studies/NCT07192432>, <https://clinicaltrials.gov/search?intr=VNX-202> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "In vivo gene therapy: AAV vector encoding a bispecific T-cell engager" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/vironexis-biotherapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07192432/> .